Feasibility of Circulating Tumor DNA Based Minimal Residual Disease-Guided Adjuvant Therapy in Locally Advanced Gastric Cancer With Neoadjuvant Treatment
Clinical trial NCT07508956 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07508956
- Sponsor
- Shanghai Zhongshan Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-01
- Primary completion
- 2029-03-31
- Enrollment
- 304
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.